(Q72891210)
Statements
A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5-fluorouracil. A regimen associated with major toxicity in patients with advanced non-small lung cancer. European Lung Cancer Working Party (English)
J Klastersky
J P Sculier
F Ries
G Dabouis
P Libert
J Schmerber
J Thiriaux
M C Berchier
G Bureau
1 September 1994